Clinical Trials Browser

Phase 2 × Pancreatic cancer, adult × nimotuzumab × Clear all

NCT07277452 2025-12-11

NOTABLE-309

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic cancer, adult

NCT06938503 2025-04-22

AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic cancer, adult